Terms: = Pancreatic cancer AND SMARCB1, Ini1, 6598, ENSG00000099956, Snr1, SNF5L1, RDT, BAF47, hSNFS, SNF5, INI1, Sfh1p, Q12824
24 results:
1. SWI/SNF chromatin remodeling complex in pancreatic ductal adenocarcinoma: Clinicopathologic and immunohistochemical study.
Chen IY; Ettel MG; Bell PD; Huber AR; Findeis-Hosey JJ; Wang W; Hezel AF; Dunne RF; Drage MG; Agostini-Vulaj D
Hum Pathol; 2024 Feb; 144():40-45. PubMed ID: 38307342
[TBL] [Abstract] [Full Text] [Related]
2. Molecular and Functional Heterogeneity of Primary pancreatic Neuroendocrine Tumors and Metastases.
Guo Y; Tian C; Cheng Z; Chen R; Li Y; Su F; Shi Y; Tan H
Neuroendocrinology; 2023; 113(9):943-956. PubMed ID: 37232011
[TBL] [Abstract] [Full Text] [Related]
3. Medullary carcinoma of the ampulla has distinct clinicopathologic characteristics including common association with microsatellite instability and PD-L1 expression.
Xue Y; Balci S; Pehlivanoglu B; Muraki T; Memis B; Saka B; Kim G; Bandyopadhyay S; Knight J; El-Rayes B; Kooby D; Maithel SK; Sarmiento J; Basturk O; Reid MD; Adsay V
Hum Pathol; 2023 Jan; 131():38-46. PubMed ID: 36502926
[TBL] [Abstract] [Full Text] [Related]
4. Relationship between cellular morphology and abnormality of SWI/SNF complex subunits in pancreatic undifferentiated carcinoma.
Yamamoto T; Kohashi K; Yamada Y; Kawata J; Sakihama K; Matsuda R; Koga Y; Aishima S; Nakamura M; Oda Y
J Cancer Res Clin Oncol; 2022 Nov; 148(11):2945-2957. PubMed ID: 34817661
[TBL] [Abstract] [Full Text] [Related]
5. SWI/SNF complex alterations as a biomarker of immunotherapy efficacy in pancreatic cancer.
Botta GP; Kato S; Patel H; Fanta P; Lee S; Okamura R; Kurzrock R
JCI Insight; 2021 Sep; 6(18):. PubMed ID: 34375311
[TBL] [Abstract] [Full Text] [Related]
6. Radiodynamic Therapy Using TAT Peptide-Targeted Verteporfin-Encapsulated PLGA Nanoparticles.
Clement S; Anwer AG; Pires L; Campbell J; Wilson BC; Goldys EM
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34204001
[TBL] [Abstract] [Full Text] [Related]
7. Loss of switch/sucrose non-fermenting complex protein expression in undifferentiated gastrointestinal and pancreatic carcinomas.
Tessier-Cloutier B; Schaeffer DF; Bacani J; Marginean CE; Kalloger S; Köbel M; Lee CH
Histopathology; 2020 Jul; 77(1):46-54. PubMed ID: 32413172
[TBL] [Abstract] [Full Text] [Related]
8. p53 Is a Master Regulator of Proteostasis in smarcb1-Deficient Malignant Rhabdoid Tumors.
Carugo A; Minelli R; Sapio L; Soeung M; Carbone F; Robinson FS; Tepper J; Chen Z; Lovisa S; Svelto M; Amin S; Srinivasan S; Del Poggetto E; Loponte S; Puca F; Dey P; Malouf GG; Su X; Li L; Lopez-Terrada D; Rakheja D; Lazar AJ; Netto GJ; Rao P; Sgambato A; Maitra A; Tripathi DN; Walker CL; Karam JA; Heffernan TP; Viale A; Roberts CWM; Msaouel P; Tannir NM; Draetta GF; Genovese G
Cancer Cell; 2019 Feb; 35(2):204-220.e9. PubMed ID: 30753823
[TBL] [Abstract] [Full Text] [Related]
9. Mutations in BRCA1, BRCA2, and PALB2, and a panel of 50 cancer-associated genes in pancreatic ductal adenocarcinoma.
Takeuchi S; Doi M; Ikari N; Yamamoto M; Furukawa T
Sci Rep; 2018 May; 8(1):8105. PubMed ID: 29802286
[TBL] [Abstract] [Full Text] [Related]
10. Cytologic features and clinical implications of undifferentiated carcinoma with osteoclastic giant cells of the pancreas: An analysis of 15 cases.
Reid MD; Muraki T; HooKim K; Memis B; Graham RP; Allende D; Shi J; Schaeffer DF; Singh R; Basturk O; Adsay V
Cancer Cytopathol; 2017 Jul; 125(7):563-575. PubMed ID: 28371566
[TBL] [Abstract] [Full Text] [Related]
11. Protein Turnover Provides pancreatic cancer Target.
Cancer Discov; 2017 Apr; 7(4):345-346. PubMed ID: 28228393
[TBL] [Abstract] [Full Text] [Related]
12. Synthetic vulnerabilities of mesenchymal subpopulations in pancreatic cancer.
Genovese G; Carugo A; Tepper J; Robinson FS; Li L; Svelto M; Nezi L; Corti D; Minelli R; Pettazzoni P; Gutschner T; Wu CC; Seth S; Akdemir KC; Leo E; Amin S; Molin MD; Ying H; Kwong LN; Colla S; Takahashi K; Ghosh P; Giuliani V; Muller F; Dey P; Jiang S; Garvey J; Liu CG; Zhang J; Heffernan TP; Toniatti C; Fleming JB; Goggins MG; Wood LD; Sgambato A; Agaimy A; Maitra A; Roberts CW; Wang H; Viale A; DePinho RA; Draetta GF; Chin L
Nature; 2017 Feb; 542(7641):362-366. PubMed ID: 28178232
[TBL] [Abstract] [Full Text] [Related]
13. Duodenum-preserving pancreatic resection versus pancreaticoduodenectomy for chronic pancreatitis.
Gurusamy KS; Lusuku C; Halkias C; Davidson BR
Cochrane Database Syst Rev; 2016 Feb; 2(2):CD011521. PubMed ID: 26837472
[TBL] [Abstract] [Full Text] [Related]
14. Identification of the BRAF V600E mutation in gastroenteropancreatic neuroendocrine tumors.
Park C; Ha SY; Kim ST; Kim HC; Heo JS; Park YS; Lauwers G; Lee J; Kim KM
Oncotarget; 2016 Jan; 7(4):4024-35. PubMed ID: 26684240
[TBL] [Abstract] [Full Text] [Related]
15. pancreatic undifferentiated rhabdoid carcinoma: KRAS alterations and smarcb1 expression status define two subtypes.
Agaimy A; Haller F; Frohnauer J; Schaefer IM; Ströbel P; Hartmann A; Stoehr R; Klöppel G
Mod Pathol; 2015 Feb; 28(2):248-60. PubMed ID: 25103069
[TBL] [Abstract] [Full Text] [Related]
16. Genetic variants in the SWI/SNF complex and smoking collaborate to modify the risk of pancreatic cancer in a Chinese population.
Zhu B; Tian J; Zhong R; Tian Y; Chen W; Qian J; Zou L; Xiao M; Shen N; Yang H; Lou J; Qiu Q; Ke J; Lu X; Song W; Li H; Liu L; Wang L; Miao X
Mol Carcinog; 2015 Sep; 54(9):761-8. PubMed ID: 24585446
[TBL] [Abstract] [Full Text] [Related]
17. Schwannomatosis presenting as pancreatic and submandibular gland schwannoma.
Val-Bernal JF; Mayorga M; Sedano-Tous MJ
Pathol Res Pract; 2013 Dec; 209(12):817-22. PubMed ID: 24054034
[TBL] [Abstract] [Full Text] [Related]
18. The clinical significance of SWI/SNF complex in pancreatic cancer.
Numata M; Morinaga S; Watanabe T; Tamagawa H; Yamamoto N; Shiozawa M; Nakamura Y; Kameda Y; Okawa S; Rino Y; Akaike M; Masuda M; Miyagi Y
Int J Oncol; 2013 Feb; 42(2):403-10. PubMed ID: 23229642
[TBL] [Abstract] [Full Text] [Related]
19. Nuclear export of proteins and drug resistance in cancer.
Turner JG; Dawson J; Sullivan DM
Biochem Pharmacol; 2012 Apr; 83(8):1021-32. PubMed ID: 22209898
[TBL] [Abstract] [Full Text] [Related]
20. Change in the growth rate of localized pancreatic adenocarcinoma in response to gemcitabine, bevacizumab, and radiation therapy on MDCT.
Rezai P; Yaghmai V; Tochetto SM; Galizia MS; Miller FH; Mulcahy MF; Small W
Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):452-9. PubMed ID: 21570199
[TBL] [Abstract] [Full Text] [Related]
[Next]
